Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-06-07
2005-06-07
Canella, Karen A. (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007230, C435S007800, C436S064000, C436S503000
Reexamination Certificate
active
06902890
ABSTRACT:
The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating cancer.
REFERENCES:
patent: 5543296 (1996-08-01), Sobol et al.
patent: 5747264 (1998-05-01), Schmidt et al.
patent: 5837498 (1998-11-01), Olsen et al.
patent: 5877290 (1999-03-01), Olsen et al.
patent: 5994103 (1999-11-01), Olsen et al.
patent: 5994301 (1999-11-01), Olsen et al.
patent: 6020478 (2000-02-01), Hillman et al.
patent: 6027887 (2000-02-01), Zavada et al.
patent: 6110675 (2000-08-01), Cohen et al.
patent: 2002/0042372 (2002-04-01), Olsen et al.
patent: 1033401 (2000-09-01), None
patent: 1121936 (2001-08-01), None
patent: 0229880 (2000-08-01), None
patent: WO 95/24411 (1995-09-01), None
patent: WO 95/34650 (1995-12-01), None
patent: WO 96/13610 (1996-05-01), None
patent: WO 98/20165 (1998-05-01), None
patent: WO 98/24914 (1998-06-01), None
patent: WO 98/45436 (1998-10-01), None
patent: WO 00/09657 (2000-02-01), None
patent: WO 00/16795 (2000-03-01), None
patent: WO 00/24913 (2000-05-01), None
patent: WO 00/55174 (2000-09-01), None
patent: WO 00/57903 (2000-10-01), None
patent: WO 01/00828 (2001-01-01), None
patent: WO 01/05422 (2001-01-01), None
patent: WO 01/05828 (2001-01-01), None
patent: WO 01/14550 (2001-03-01), None
patent: WO 01/23541 (2001-04-01), None
patent: WO 01/30969 (2001-05-01), None
patent: WO 01/32209 (2001-05-01), None
Shantz and Pegg, “Translational regulation of ornithine decarboxylase and other enzymes”, International J of Biochemistry and Cell Biology, vol. 31, pp. 107-122.
McClean and Hill, “Evidence of post-translational regulation of p-glycoprotein”, European J. of Cancer, vol. 29A, pp. 2243-2248.
Fu et al, “Translational regulation of human p53 gene expression”, EMBO, vol. 15, pp. 4392-4401.
Charpentier et al., “STC2 and E2IG1, Two Novel Breast Cancer Biomarkers”, Proceedings of the American Association for Cancer Research Annual 2001 42:628 XP001119829.
Chen et al., “Evidences of human stanniocalcin 1 and amino acid transporter ATBO+ as potential diagnostic marker for non-small cell lung cancer”, American Association for Cancer Research Annual 2002 43:518-519 XP001119830.
Kahn et al., “Gene Expression Profiling in an in Vitro Model of Angiogenesis”, American Journal of Pathology 2000 156(6) :1887-1900 XP-002178225.
Liang et al., “Differential Display and Cloning of Messenger RNAs from Human Breast Cancer versus Mammary Epithelial Cells1”, Cancer Research 1992 52:6966-6968 XP002032010.
Chang et al., A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol. 1995; vol. 112:241-247.
Chang et al., Human Stanniocalcin (STC): Genomic Structure, Chromosomal Localization, and the Presence of CAG Trinucleotide Repeats, Genomics, 1998; vol. 47:393-398.
De Niu et al., Immunolocalization of stanniocalcin in human kidney. Mol Cell Endocrinol. Feb. 1998; vol. 137(2):155-9.
Ellis et al., Post-transcriptional Regulation of the Stanniocalcin Gene by Calcium. JBC. Jan. 27, 1995;vol. 270(4):1960-65.
Fujiwara et al., Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. Int. J. Oncol. Apr. 2000;vol. 16:799-804.
Haddad et al., Immunocytochemical Localization of Stannniocalcin Cells in the Rat Kidney. Endocrinology. 1996;vol. 137(5):2113-17.
Olsen et al., Human stanniocalcin: A possible hormonal regulator of mineral metabolism. Biochemistry. 1996;vol. 93:1792-96.
Varghese et al., Comparative Analysis of Mammalian Stanniocalcin Genes. Endocrinology. 1998;vol. 139(11):4714-25.
Verbost et al., Studies on stanniocalcin: characterization of bioactive and antigenic domains of the hormone. Mol Cell Endocrinol. 1993;vol. 93:11-16.
Wagner et al., Immunological and biological evidence for a stanniocalcin-like hormone in human kidney. Physiology. Mar. 1995;vol. 92:1871-75.
DiMattia et al., Molecular cloning and characterization of stanniocalcin-related protein. Molecular and Cellular Endocrinology. 1998;vol. 146:137-140.
Niu et al, Development of a human stanniocalcin radioimmunoassay: serum and tissue hormone levels and pharmacokinetics in the rat, 2000, vol. 162: 131-144.
Radman et al., Evidence for calcium-sensing receptor mediated stanniocalcin secretion in fish, Molecular Cell Endocrinology, 2002, vol. 186: 111-119.
Chen Sei-Yu
Macina Roberto A.
Recipon Herve
Sun Yongming
Canella Karen A.
diaDexus, Inc.
Letts Nathan P.
Licata & Tyrrell PC
LandOfFree
Method of diagnosing monitoring, staging, imaging and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing monitoring, staging, imaging and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing monitoring, staging, imaging and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522260